Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface - PubMed (original) (raw)
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface
R A Lamb et al. Cell. 1985 Mar.
Abstract
The influenza A virus M2 protein is expressed abundantly at the cell surface, and in addition to the hemagglutinin (HA) and neuraminidase (NA), is a third virus-specific membrane protein. M2 has an internal hydrophobic membrane anchorage domain and associates with the same cellular membrane fractions as HA and NA. Trypsin treatment of infected cells and immunoprecipitation with site-specific antisera indicate that a minimum of 18 NH2-terminal amino acids of M2 are exposed at the cell surface. Ten NH2-terminal residues are conserved in all strains of influenza A virus for which sequences are available. Antibodies can recognize M2 on the cell surface and therefore it may be an infected-cell surface antigen. We discuss properties of M2 that match it to the elusive major target molecule on influenza A virus-infected cells for cross-reactive cytotoxic T cells.
Similar articles
- Lateral Organization of Influenza Virus Proteins in the Budozone Region of the Plasma Membrane.
Leser GP, Lamb RA. Leser GP, et al. J Virol. 2017 Apr 13;91(9):e02104-16. doi: 10.1128/JVI.02104-16. Print 2017 May 1. J Virol. 2017. PMID: 28202765 Free PMC article. - Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells.
Jones LV, Compans RW, Davis AR, Bos TJ, Nayak DP. Jones LV, et al. Mol Cell Biol. 1985 Sep;5(9):2181-9. doi: 10.1128/mcb.5.9.2181-2189.1985. Mol Cell Biol. 1985. PMID: 3016520 Free PMC article. - Influenza virus M2 protein and haemagglutinin conformation changes during intracellular transport.
Ciampor F, Cmarko D, Cmarková J, Závodská E. Ciampor F, et al. Acta Virol. 1995 Jun;39(3):171-81. Acta Virol. 1995. PMID: 8579000 Review. - Progress on adenovirus-vectored universal influenza vaccines.
Xiang K, Ying G, Yan Z, Shanshan Y, Lei Z, Hongjun L, Maosheng S. Xiang K, et al. Hum Vaccin Immunother. 2015;11(5):1209-22. doi: 10.1080/21645515.2015.1016674. Hum Vaccin Immunother. 2015. PMID: 25876176 Free PMC article. Review.
Cited by
- The M2 Protein of the Influenza A Virus Interacts with PEX19 to Facilitate Virus Replication by Disrupting the Function of Peroxisome.
Liu T, Liang L, Zhao P, Lin W, Zhuang Y, Jiang L, Chen H, Li C. Liu T, et al. Viruses. 2024 Aug 16;16(8):1309. doi: 10.3390/v16081309. Viruses. 2024. PMID: 39205283 Free PMC article. - Activation of the influenza B M2 proton channel (BM2).
Yue Z, Wu J, Teng D, Wang Z, Voth GA. Yue Z, et al. bioRxiv [Preprint]. 2024 Jul 26:2024.07.26.605324. doi: 10.1101/2024.07.26.605324. bioRxiv. 2024. PMID: 39091734 Free PMC article. Preprint. - Intranasal Vaccination with Recombinant TLR2-Active Outer Membrane Vesicles Containing Sequential M2e Epitopes Protects against Lethal Influenza a Challenge.
Kannan N, Choi A, Rivera De Jesus MA, Wei PM, Sahler JM, Curley SM, August A, DeLisa MP, Whittaker GR, Putnam D. Kannan N, et al. Vaccines (Basel). 2024 Jun 29;12(7):724. doi: 10.3390/vaccines12070724. Vaccines (Basel). 2024. PMID: 39066362 Free PMC article. - The role of an amphiphilic helix and transmembrane region in the efficient acylation of the M2 protein from influenza virus.
Meng X, Templeton C, Clementi C, Veit M. Meng X, et al. Sci Rep. 2023 Nov 2;13(1):18928. doi: 10.1038/s41598-023-45945-z. Sci Rep. 2023. PMID: 37919373 Free PMC article. - A structure and knowledge-based combinatorial approach to engineering universal scFv antibodies against influenza M2 protein.
Kumar U, Goyal P, Madni ZK, Kamble K, Gaur V, Rajala MS, Salunke DM. Kumar U, et al. J Biomed Sci. 2023 Jul 25;30(1):56. doi: 10.1186/s12929-023-00950-2. J Biomed Sci. 2023. PMID: 37491224 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources